Review
Cell Biology
Yoshiya Ito, Kanako Hosono, Hideki Amano
Summary: The liver has the ability to regenerate in response to acute liver injury, but liver ischemia-reperfusion injury (IRI) remains a major problem in liver surgery. Non-parenchymal cells in the liver play critical roles in liver repair and regeneration, and recent technological advances have provided insights into their heterogeneity. This review discusses the progress in understanding the biology of liver non-parenchymal cells and the functional role of each cell component in response to liver IRI.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2023)
Article
Virology
Alperen Aksakal, Bugra Kerget, Ferhan Kerget, Seda Askin
Summary: The study revealed the correlation between serum migration inhibitory factor (MIF) level and disease severity in COVID-19, with higher MIF levels potentially indicating a more severe condition. MIF levels can serve as an important predictive indicator for early disease prognosis in COVID-19.
JOURNAL OF MEDICAL VIROLOGY
(2021)
Article
Biochemistry & Molecular Biology
Juan Cai, Lin Huang, Hongri Tang, Hongling Xu, Lingjun Wang, Minghui Zheng, Hongsong Yu, Hui Liu
Summary: The MIF produced by Thelazia callipaeda can induce M2-like macrophage polarization through TLR4-mediated activation of the PI3K-Akt pathway, potentially aiding in disrupting the host immune system.
Article
Biochemistry & Molecular Biology
Mauro Vasella, Stefan Wolf, Eamon C. Francis, Gerrit Grieb, Pablo Pfister, Gregory Reid, Juergen Bernhagen, Nicole Lindenblatt, Epameinondas Gousopoulos, Bong-Sung Kim
Summary: Lipedema is a chronic disorder mainly affecting women, with an unknown etiology. Recent research suggests that the accumulation and polarization of macrophages may be involved in lipedema. This study provides evidence for the potential involvement of the MIF family, specifically the MIF-1-CD74 axis, in lipedema.
Article
Biochemistry & Molecular Biology
Ji Ae Kim, Ye Young Kim, Seung Hak Lee, Chul Jung, Mi Hee Kim, Dae Yul Kim
Summary: The macrophage migration inhibitory factor (MIF) exerts a neuroprotective effect, facilitating neurological recovery and protecting brain tissue from ischemic injury in an in vivo model of ischemic stroke.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Biochemistry & Molecular Biology
Yuxin Zhang, Zhonglong Liu, Kexin Wang, Shenji Lu, Shuai Fan, Lili Xu, Bin Cai
Summary: This study revealed the role of MIF and TGF-β1 in post-traumatic joint contracture, showing that MIF can enhance TGF-β1 production in fibroblasts through MAPK signaling, leading to fibroblast function changes and joint capsule fibrosis. Further investigation into this mechanism may lead to potential therapeutic targets for PTJC.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
(2021)
Article
Fisheries
Zhengshi Zhang, Xiucong Hu, Qianying Diao, Panpan Zhang, Ying Wu, Zhenjie Cao, Yongcan Zhou, Chunsheng Liu, Yun Sun
Summary: In this study, a macrophage migration inhibitory factor (TroMIF) was identified from golden pompano and its function was analyzed. TroMIF showed high similarity with other known MIF sequences and was most closely related to large yellow croaker. TroMIF was highly expressed in the liver and head kidney and its expression was up-regulated after E. tarda infection. In vitro experiments showed that rTroMIF could inhibit the migration of lymphocytes and macrophages and enhance macrophage phagocytic activity. Furthermore, rTroMIF increased the expression levels of pro-inflammatory cytokines and had enzymatic redox activity. Overexpression of TroMIF enhanced the ability to resist E. tarda infection, while knockdown of TroMIF expression increased the bacterial load. These results suggest that TroMIF plays an important role in antibacterial immunity.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Caroline Swoboda, Lena Deloch, Claudia von Zimmermann, Tanja Richter-Schmidinger, Bernd Lenz, Johannes Kornhuber, Christiane Muehle
Summary: This study investigated the potential of MIF at genetic, expression, and protein levels as a risk factor and biomarker for diagnosing, monitoring, or predicting MDD. The results suggest a genetic effect of MIF in women but do not provide strong evidence for its utility as a biomarker for MDD.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Dentistry, Oral Surgery & Medicine
D. Zhang, T. Xu, Q. Xu, Q. Dong, Y. Luo, L. Gao, Y. Pan
Summary: This study revealed significant increases in levels of MCP-1 and MIF in periodontitis patients, along with enhanced secretion of MIF in gingival epithelial tissue. Limited evidence suggested a correlation between MIF and periodontal conditions, with Porphyromonas gingivalis potentially contributing to periodontitis development and progression through MIF.
ARCHIVES OF ORAL BIOLOGY
(2021)
Article
Critical Care Medicine
Tianlong Li, Jiahao Zhang, Minghui Long, Xiaofang Jiang, Cheng Yang, Fengqin Wang, Lianjiu Su, Zhiyong Peng
Summary: This study found that serum MIF level might serve as a biomarker for predicting the occurrence, development, and outcomes of septic AKI.
Article
Oncology
Luai Al-Marzouki, Vivian S. Stavrakos, Sanjima Pal, Betty Giannias, France Bourdeau, Roni Rayes, Nicholas Bertos, Sara Najmeh, Jonathan D. Spicer, Jonathan Cools-Lartigue, Swneke D. Bailey, Lorenzo Ferri, Veena Sangwan
Summary: This study suggests that the contact between gastric adenocarcinoma cells and MA increases their ability to adhere to peritoneal cells. This finding is validated through ex vivo and in vivo experiments, and it is found that MIF and VEGF are elevated in MA samples from GC patients. Agents targeting MIF or VEGF may be used for the treatment or prevention of PM in GC patients.
Review
Physiology
Yiwei Du, Hao Hao, Heng Ma, Hongbao Liu
Summary: Acute kidney injury (AKI) is a complex clinical syndrome with multiple etiologies and pathogenesis. Macrophage migration inhibitory factor (MIF) family proteins play a crucial role in AKI, but they can have both protective and detrimental effects on renal injury. Therefore, understanding the biological role and potential therapeutic targets of MIF family proteins in AKI is of great importance.
FRONTIERS IN PHYSIOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Du-Hwan Kim, Sun-Up Noh, Seoung-Wan Chae, Sang-Jun Kim, Yong-Taek Lee
Summary: The study found that under hyperglycemic conditions, MIF can alter the differentiation of TdSCs by enhancing osteochondrogenic differentiation, thereby affecting tendon homeostasis. These are preliminary findings and need to be confirmed in further studies.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Immunology
Krishnamoorthi Sumaiya, Charles Solomon Akino Mercy, Gangatharan Muralitharan, Abdurahman Hajinur Hirad, Abdullah A. Alarfaj, Kalimuthusamy Natarajaseenivasan
Summary: This study evaluated the diagnostic value of macrophage migration inhibitory factor (MIF) for leptospirosis. The results showed that serum MIF levels were significantly elevated in leptospirosis patients and correlated with disease severity and progression. Serum MIF exhibited high sensitivity and specificity, making it a potential rapid diagnostic marker for leptospirosis.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2022)
Article
Infectious Diseases
Felipe Dominguez Machado, Mirela Gehlen, Vitoria Schmidt Caron, Gabriel Tassi Mousquer, Graziele Lima Bello, Camila Anton, Rafaela Manzoni Bernardi, Alana Ambos Freitas, Gisela Unis, Elis Regina Dalla Costa, Maria Lucia Rosa Rossetti, Denise Rossato Silva
Summary: The genotype 5/5 and allele 5 of MIF-794 CATT (5-8) were more common among TB patients compared to controls. There was no difference in the prevalence of genotypes 7/X+8/X between cases and controls.
Article
Oncology
Keqiang Chen, Teizo Yoshimura, Xiaohong Yao, Wanghua Gong, Jiaqiang Huang, Amiran K. Dzutsev, John McCulloch, Colm O'hUigin, Xiu-wu Bian, Giorgio Trinchieri, Ji Ming Wang
Summary: CRAMP plays a protective role in the mouse colon against inflammation, inflammation-associated carcinogenesis, and disrupted microbiome balance. Epithelial cell-derived CRAMP is crucial for normal development and repair of colon crypts, while myeloid cell-derived CRAMP enhances colon epithelial resistance to bacterial invasion during acute inflammation.
JOURNAL OF PATHOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Xianwen Ren, Wen Wen, Xiaoying Fan, Wenhong Hou, Bin Su, Pengfei Cai, Jiesheng Li, Yang Liu, Fei Tang, Fan Zhang, Yu Yang, Jiangping He, Wenji Ma, Jingjing He, Pingping Wang, Qiqi Cao, Fangjin Chen, Yuqing Chen, Xuelian Cheng, Guohong Deng, Xilong Deng, Wenyu Ding, Yingmei Feng, Rui Gan, Chuang Guo, Weiqiang Guo, Shuai He, Chen Jiang, Juanran Liang, Yi-min Li, Jun Lin, Yun Ling, Haofei Liu, Jianwei Liu, Nianping Liu, Shu-Qiang Liu, Meng Luo, Qiang Ma, Qibing Song, Wujianan Sun, GaoXiang Wang, Feng Wang, Ying Wang, Xiaofeng Wen, Qian Wu, Gang Xu, Xiaowei Xie, Xinxin Xiong, Xudong Xing, Hao Xu, Chonghai Yin, Dongdong Yu, Kezhuo Yu, Jin Yuan, Biao Zhang, Peipei Zhang, Tong Zhang, Jincun Zhao, Peidong Zhao, Jianfeng Zhou, Wei Zhou, Sujuan Zhong, Xiaosong Zhong, Shuye Zhang, Lin Zhu, Ping Zhu, Bin Zou, Jiahua Zou, Zengtao Zuo, Fan Bai, Xi Huang, Penghui Zhou, Qinghua Jiang, Zhiwei Huang, Jin-Xin Bei, Lai Wei, Xiu-Wu Bian, Xindong Liu, Tao Cheng, Xiangpan Li, Pingsen Zhao, Fu-Sheng Wang, Hongyang Wang, Bing Su, Zheng Zhang, Kun Qu, Xiaoqun Wang, Jiekai Chen, Ronghua Jin, Zemin Zhang
Summary: The study revealed the presence of immune response dysfunction in COVID-19 patients, with different peripheral immune subtype changes associated with clinical features such as age, sex, severity, and disease stages. Additionally, dramatic transcriptomic changes were observed within virus-infected cells, and upregulation of S100A8/A9 in peripheral blood may contribute to the cytokine storms frequently observed in severe patients.
Article
Biochemistry & Molecular Biology
Zhengrong Zhang, You Zheng, Zubiao Niu, Bo Zhang, Chenxi Wang, Xiaohong Yao, Haoran Peng, Del Nonno Franca, Yunyun Wang, Yichao Zhu, Yan Su, Meng Tang, Xiaoyi Jiang, He Ren, Meifang He, Yuqi Wang, Lihua Gao, Ping Zhao, Hanping Shi, Zhaolie Chen, Xiaoning Wang, Mauro Piacentini, Xiuwu Bian, Gerry Melino, Liang Liu, Hongyan Huang, Qiang Sun
Summary: In COVID-19 patients, SARS-CoV-2 infection leads to the presence of heterotypic cell-in-cell structures in lung tissues with lymphocytes inside multinucleate syncytia. The membrane fusion induced by the spike glycoprotein is controlled by a bi-arginine motif, and candidate anti-viral drugs can efficiently inhibit this process. This study provides insights into the molecular and cellular mechanisms of SARS-CoV-2 pathogenesis and identifies potential novel targets for COVID-19 therapy.
CELL DEATH AND DIFFERENTIATION
(2021)
Editorial Material
Immunology
Jinghe Zhang, Haibo Wu, XiaoHong Yao, Dingyu Zhang, Yonggang Zhou, Binqing Fu, Wei Wang, Heng Li, Zhe Wang, Ziming Hu, Yong Ren, Rui Sun, Zhigang Tian, Xiuwu Bian, Haiming Wei
CELLULAR & MOLECULAR IMMUNOLOGY
(2021)
Article
Oncology
Weiqi Dang, Jingfang Xiao, Qinghua Ma, Jingya Miao, Mianfu Cao, Lu Chen, Yu Shi, Xiaohong Yao, Shichang Yu, Xindong Liu, Youhong Cui, Xia Zhang, Xiuwu Bian
Summary: The study demonstrates that a p38MAPK inhibitor can reduce macrophages/microglia accumulation in glioma and prolong the survivals of glioma-bearing mice, potentially through inhibiting PD-L1 expression. The combination therapy of p38MAPK inhibitor with PD-L1 antibody effectively prolongs the survivals of TMZ-resistant GBM-bearing hosts and modulates the immune microenvironment within the tumor. Further clinical studies are needed to confirm the safety and efficacy of this combination therapy.
BRAIN TUMOR PATHOLOGY
(2021)
Correction
Biochemistry & Molecular Biology
Xianwen Ren, Wen Wen, Xiaoying Fan, Wenhong Hou, Bin Su, Pengfei Cai, Jiesheng Li, Yang Liu, Fei Tang, Fan Zhang, Yu Yang, Jiangping He, Wenji Ma, Jingjing He, Pingping Wang, Qiqi Cao, Fangjin Chen, Yuqing Chen, Xuelian Cheng, Guohong Deng, Xilong Deng, Wenyu Ding, Yingmei Feng, Rui Gan, Chuang Guo, Weiqiang Guo, Shuai He, Chen Jiang, Juanran Liang, Yi-min Li, Jun Lin, Yun Ling, Haofei Liu, Jianwei Liu, Nianping Liu, Shu-Qiang Liu, Meng Luo, Qiang Ma, Qibing Song, Wujianan Sun, GaoXiang Wang, Feng Wang, Ying Wang, Xiaofeng Wen, Qian Wu, Gang Xu, Xiaowei Xie, Xinxin Xiong, Xudong Xing, Hao Xu, Chonghai Yin, Dongdong Yu, Kezhuo Yu, Jin Yuan, Biao Zhang, Peipei Zhang, Tong Zhang, Jincun Zhao, Peidong Zhao, Jianfeng Zhou, Wei Zhou, Sujuan Zhong, Xiaosong Zhong, Shuye Zhang, Lin Zhu, Ping Zhu, Bin Zou, Jiahua Zou, Zengtao Zuo, Fan Bai, Xi Huang, Penghui Zhou, Qinghua Jiang, Zhiwei Huang, Jin-Xin Bei, Lai Wei, Xiu-Wu Bian, Xindong Liu, Tao Cheng, Xiangpan Li, Pingsen Zhao, Fu-Sheng Wang, Hongyang Wang, Bing Su, Zheng Zhang, Kun Qu, Xiaoqun Wang, Jiekai Chen, Ronghua Jin, Zemin Zhang
Article
Medicine, Research & Experimental
Min Luo, Yu-Qi Liu, Hua Zhang, Chun-Hua Luo, Qing Liu, Wen-Ying Wang, Zhi-Cheng He, Cong Chen, Xiao-Ning Zhang, Min Mao, Kai-Di Yang, Chao Wang, Xiao-Qing Chen, Wen-Juan Fu, Qin Niu, Xiu-Wu Bian, Yu Shi, Yi-Fang Ping
Summary: The study demonstrates that CPT1A plays a critical role in regulating mitochondrial dynamics and GSC differentiation in glioblastoma. Overexpression of CPT1A inhibits GSC self-renewal and promotes mitochondrial fusion, while disruption of CPT1A leads to mitochondrial fission and reprogramming of non-stem tumor cells towards GSC features. This suggests that CPT1A could be a potential target for differentiation therapy in GBM.
LABORATORY INVESTIGATION
(2022)
Article
Cell Biology
Si Wang, Xiaohong Yao, Shuai Ma, Yifang Ping, Yanling Fan, Shuhui Sun, Zhicheng He, Yu Shi, Liang Sun, Shiqi Xiao, Moshi Song, Jun Cai, Jiaming Li, Rui Tang, Liyun Zhao, Chaofu Wang, Qiaoran Wang, Lei Zhao, Huifang Hu, Xindong Liu, Guoqiang Sun, Lu Chen, Guoqing Pan, Huaiyong Chen, Qingrui Li, Peipei Zhang, Yuanyuan Xu, Huyi Feng, Guo-Guang Zhao, Tianzi Wen, Yungui Yang, Xuequan Huang, Wei Li, Zhenhua Liu, Hongmei Wang, Haibo Wu, Baoyang Hu, Yong Ren, Qi Zhou, Jing Qu, Weiqi Zhang, Guang-Hui Liu, Xiu-Wu Bian
Summary: This study provides insights into the molecular basis of lung pathology in COVID-19 patients through multi-omics and single-nucleus transcriptomic analysis, identifying pathological features associated with SARS-CoV-2 infection such as hyperinflammation, alveolar epithelial cell exhaustion, vascular changes, and fibrosis. It also highlights lung senescence as a molecular state of COVID-19 pathology and suggests FOXO3A suppression as a potential mechanism for COVID-19 pulmonary fibrosis.
NATURE CELL BIOLOGY
(2021)
Article
Cell Biology
Guojuan Jiang, Juchuanli Tu, Lei Zhou, Mengxue Dong, Jue Fan, Zhaoxia Chang, Lixing Zhang, Xiuwu Bian, Suling Liu
Summary: The study constructed a single-cell atlas of tumor progression stages in a breast cancer mouse model, revealing the role of ERlow epithelial cell lineage in tumor initiation and the blockade of differentiation in ERhigh epithelial cell lineage. Furthermore, a stem-like cell cluster was identified within ERlow epithelial cells, showing heterogeneity. This study also highlighted the dynamics of immune cell infiltration and the potential cross-talk between BCSCs and immune cells during breast tumor progression.
CELL DEATH & DISEASE
(2021)
Correction
Genetics & Heredity
Fang Zheng, Yi-Ji Liao, Mu-Yan Cai, Tian-Hao Liu, Shu-Peng Chen, Pei-Hong Wu, Long Wu, Xiu-Wu Bian, Xin-Yuan Guan, Yi-Xin Zeng, Yun-Fei Yuan, Hsiang-Fu Kung, Dan Xie
Article
Oncology
Kaidi Yang, Yu Shi, Min Luo, Min Mao, Xiaoning Zhang, Cong Chen, Yuqi Liu, Zhicheng He, Qing Liu, Wenying Wang, Chunhua Luo, Wen Yin, Chao Wang, Qin Niu, Hui Zeng, Xiu-Wu Bian, Yi-Fang Ping
Summary: This study used single-cell RNA sequencing and bulk RNA sequencing data to reveal the immune evasion mechanisms of GBM cells and their interactions with immune cells. A new subset of GBM cells, TC-6, was identified with immune-invading characteristics and synergy with tumor-associated macrophages to create an immune-suppressive environment. Three immune subtypes were also identified, with C3 GBMs being enriched with TC-6 cells and immunosuppressive macrophages, which were associated with reduced efficacy of anti-PD-1 treatment. The findings provide new insights into optimizing anti-GBM immunotherapy.
Article
Materials Science, Multidisciplinary
Kai Wang, Shuaishuai Ding, Lijuan Zeng, Jingrong Zhou, Yuhua Cao, Jiaqian Wu, Lu Lu, Xiu-wu Bian, Gan Tian
Summary: A dual exogenous/endogenous CA IX inhibition strategy using metal-organic framework/gold nanoparticles nanohybrids was developed for hypoxia-relief enhanced radiation therapy of triple negative breast cancer. This strategy effectively alleviated hypoxia-induced resistance by combining external and internal inhibition methods, along with radiotherapy, to achieve a synergistic therapeutic outcome.
APPLIED MATERIALS TODAY
(2021)
Article
Cell Biology
Li-Hong Wang, Sen Wei, Ye Yuan, Ming-Jun Zhong, Jiao Wang, Ze-Xuan Yan, Kai Zhou, Tao Luo, Li Liang, Xiu-Wu Bian
Summary: PARP inhibitors have limited efficacy when used alone in glioblastoma (GBM) patients, leading researchers to explore combination therapies. This study found that concurrent treatment with the PARP inhibitor olaparib and XPO1 inhibitor KPT330 showed synergistic anticancer effects on GBM cells. Mechanistically, KPT330 induced the nuclear retention of SQSTM1 and inhibited the ubiquitination of the DNA repair signal H2AX mediated by olaparib in the nucleus, inhibiting DNA damage response and repair in GBM. In the cytoplasm, KPT330 blocked autophagic flux and induced dysfunction of lysosomes, ultimately promoting cell death.
Article
Oncology
Juan Feng, Yang Lan, Feng Liu, Ye Yuan, Jia Ge, Sen Wei, Hu Luo, Jianjun Li, Tao Luo, Xiuwu Bian
Summary: The genomic instability/homologous recombination deficiency (GI/HRD) score has prognostic value in lung adenocarcinoma, particularly when combined with TP53 status, but is not applicable for all types of lung cancer.
NPJ PRECISION ONCOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Qu-Jing Gai, Zhen Fu, Jiang He, Min Mao, Xiao-Xue Yao, Yan Qin, Xi Lan, Lin Zhang, Jing-Ya Miao, Yan-Xia Wang, Jiang Zhu, Fei-Cheng Yang, Hui-Min Lu, Ze-Xuan Yan, Fang-Lin Chen, Yu Shi, Yi-Fang Ping, You-Hong Cui, Xia Zhang, Xindong Liu, Xiao-Hong Yao, Sheng-Qing Lv, Xiu-Wu Bian, Yan Wang
Summary: PDGFRA may not be necessary for PDGFA function. The study revealed EPHA2 as a potential receptor of PDGFA and identified that co-upregulation of PDGFA and EPHA2 led to worse patient prognosis and poorer therapeutic effects. Combination inhibitors targeting PDGFRA and EHA2 represent a promising therapeutic strategy for GBM treatment.
SIGNAL TRANSDUCTION AND TARGETED THERAPY
(2022)